4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tyra Biosciences, Inc. (TYRA) operates in the Biotechnology industry and is headquartered in Carlsbad, United States with about 87 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, TYRA reported $0M in revenue and ($120M) in net income.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($133M) | ($104M) | ($80M) | ($59M) | — |
| Net Income | ($120M) | ($86M) | ($69M) | ($55M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($42M) | ($36M) | ($33M) | ($32M) | ($32M) |
| Net Income | ($39M) | ($34M) | ($30M) | ($28M) | ($28M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $283M | $364M | $226M | $266M | — |
| Total Liabilities | $23M | $20M | $22M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TYRA viewer.
About TickerBase · Data methodology & sources